These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections. Trimble MR; Whurr R; Brookes G; Robertson MM Mov Disord; 1998 May; 13(3):617-9. PubMed ID: 9613771 [No Abstract] [Full Text] [Related]
3. Tourette syndrome associated with mental retardation: a single-subject treatment study with haloperidol. Rosenquist PB; Bodfish JW; Thompson R Am J Ment Retard; 1997 Mar; 101(5):497-504. PubMed ID: 9083606 [TBL] [Abstract][Full Text] [Related]
4. Tourette syndrome. Report of 19 cases. Chen HB; Lu Fei HQ Chin Med J (Engl); 1983 Jan; 96(1):45-50. PubMed ID: 6403311 [No Abstract] [Full Text] [Related]
5. The natural history of Tourette syndrome: a follow-up study. Erenberg G; Cruse RP; Rothner AD Ann Neurol; 1987 Sep; 22(3):383-5. PubMed ID: 3479043 [TBL] [Abstract][Full Text] [Related]
7. Treating Tourette syndrome with haloperidol: predictors of success. Schwabe MJ; Konkol RJ Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810 [TBL] [Abstract][Full Text] [Related]
8. Tourette syndrome in oriental children: clinical and pathophysiological considerations. Nomura Y; Segawa M Adv Neurol; 1982; 35():277-80. PubMed ID: 6959499 [No Abstract] [Full Text] [Related]
9. Gilles de la Tourette disease in multiply disabled children. Kerbeshian J; Burd L; Fisher W; Martsolf JT; Wikenhaiser M Rehabil Lit; 1985; 46(9-10):255-8. PubMed ID: 3865270 [No Abstract] [Full Text] [Related]
10. Dopaminergic dsyfunction in Tourette syndrome. Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010 [TBL] [Abstract][Full Text] [Related]
11. Gilles de la Tourette's syndrome associated with chronic schizophrenia. Sandyk R; Bamford CR Int J Neurosci; 1988 Jul; 41(1-2):83-6. PubMed ID: 3165970 [TBL] [Abstract][Full Text] [Related]
12. Manual laryngeal reposturing as a primary approach for mutational falsetto. Roy N; Peterson EA; Pierce JL; Smith ME; Houtz DR Laryngoscope; 2017 Mar; 127(3):645-650. PubMed ID: 27107407 [TBL] [Abstract][Full Text] [Related]
13. Haloperidol for Tourette's disorder plus selective mutism. Rupp SN J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):7. PubMed ID: 9893409 [No Abstract] [Full Text] [Related]
14. Predictors of clonidine response in Tourette syndrome: implications and inferences. Lichter DG; Jackson LA J Child Neurol; 1996 Mar; 11(2):93-7. PubMed ID: 8881983 [TBL] [Abstract][Full Text] [Related]
15. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder. McConville BJ; Sanberg PR; Fogelson MH; King J; Cirino P; Parker KW; Norman AB Biol Psychiatry; 1992 Apr; 31(8):832-40. PubMed ID: 1643197 [TBL] [Abstract][Full Text] [Related]
17. Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder. McConville BJ; Fogelson MH; Norman AB; Klykylo WM; Manderscheid PZ; Parker KW; Sanberg PR Am J Psychiatry; 1991 Jun; 148(6):793-4. PubMed ID: 1817466 [TBL] [Abstract][Full Text] [Related]
18. A clinical pharmacological approach to treating Tourette syndrome in children and adolescents. Kerbeshian J; Burd L Neurosci Biobehav Rev; 1988; 12(3-4):241-5. PubMed ID: 2906423 [TBL] [Abstract][Full Text] [Related]
19. Gilles de la Tourette syndrome in India: two cases. Eapen V; Srinath S Psychol Rep; 1992 Apr; 70(2):667-8. PubMed ID: 1598386 [TBL] [Abstract][Full Text] [Related]